222 related articles for article (PubMed ID: 8328200)
1. [The value of late thrombolytic perfusion in acute myocardial infarct].
Gulba DC
Z Kardiol; 1993; 82 Suppl 2():183-5. PubMed ID: 8328200
[TBL] [Abstract][Full Text] [Related]
2. [New substances and dosages for thrombolysis in acute myocardial infarct].
Zeymer U; Neuhaus KL
Z Kardiol; 1993; 82 Suppl 2():137-41. PubMed ID: 8328192
[TBL] [Abstract][Full Text] [Related]
3. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
[TBL] [Abstract][Full Text] [Related]
4. [Thrombolysis in acute myocardial infarct: prerequisites, current experiences and remaining problems].
Rapold HJ
Schweiz Med Wochenschr; 1986 Aug; 116(33):1074-87. PubMed ID: 3094141
[TBL] [Abstract][Full Text] [Related]
5. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
6. [Late thrombolysis in the therapy of acute myocardial infarct: the prospects for its wide-spread clinical use].
Chiariello M; Villari B
Cardiologia; 1991 Dec; 36(12 Suppl 1):435-41. PubMed ID: 1841799
[TBL] [Abstract][Full Text] [Related]
7. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis in the management of acute myocardial infarction. Current status and future perspectives.
Verheugt F
Rev Port Cardiol; 1998 Dec; 17(12):959-65. PubMed ID: 9973856
[TBL] [Abstract][Full Text] [Related]
9. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
10. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
[TBL] [Abstract][Full Text] [Related]
11. Regional and systemic thrombolytic therapy in acute myocardial infarction.
Hastillo A; Cowley MJ
Cardiovasc Clin; 1984; 14(3):235-45. PubMed ID: 6722853
[TBL] [Abstract][Full Text] [Related]
12. [Thrombolytic treatment in acute myocardial infarction. Choice of preparations in Norwegian hospitals].
Andreassen AK; Gullestad L; Endresen K
Tidsskr Nor Laegeforen; 1998 Jun; 118(17):2630-1. PubMed ID: 9673511
[TBL] [Abstract][Full Text] [Related]
13. [The effect of systemic thrombolytic therapy on left ventricular contractile function and on the tolerance for physical loading in patients with an acute myocardial infarct].
Shal'nev VI
Ter Arkh; 1996; 68(5):55-6. PubMed ID: 9082602
[TBL] [Abstract][Full Text] [Related]
14. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
[TBL] [Abstract][Full Text] [Related]
15. The late open artery hypothesis at the crossroad. The ACTOR study: aggressive versus conservative treatment of the infarct-related artery after acute MI. ACTOR Study Group.
G Ital Cardiol; 1999 Jan; 29(1):1-10. PubMed ID: 9987041
[TBL] [Abstract][Full Text] [Related]
16. Rapid infusion of streptokinase standard dose in acute myocardial infarction is followed by a higher rate of coronary reperfusion than standard protocol.
Tatu-Chiţoiu G; Orha I; Teodorescu C; Flueraşu A; Serban L; Bumbu A
Rom J Intern Med; 1997; 35(1-4):47-54. PubMed ID: 9562652
[TBL] [Abstract][Full Text] [Related]
17. Thrombolysis for acute myocardial infarction: drug review.
Cundiff DK
MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
[TBL] [Abstract][Full Text] [Related]
18. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy].
Chernetsov VA
Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019
[No Abstract] [Full Text] [Related]
19. [Thrombolysis in acute myocardial infarct of embolic origin].
Meléndez HR; Leiva Pons JL; Simón S; Céspedes F; Peña Duque MA
Arch Inst Cardiol Mex; 1996; 66(2):122-8. PubMed ID: 8768629
[TBL] [Abstract][Full Text] [Related]
20. The current controversies regarding reperfusion therapy for acute myocardial infarction.
Ross AM
Z Kardiol; 1993; 82 Suppl 2():113-7. PubMed ID: 8328187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
